ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Rexahn & BioSense Enter License Agreement contractpharma
April 17, 2019To advance the development and commercialization of RX-3117 for pancreatic cancer and other cancers in Greater China... -
Rexahn, Merck Partner for Cancer
contractpharma
August 22, 2018Rexahn Pharmaceuticals?has entered into a clinical trial collaboration agreement with?Merck?to evaluate the combination of Rexahn’s RX-5902 and Merck’s anti-PD-1 therapy, KEYTRUDA? (pembrolizumab) in a Phase 2 trial in patients with metastatic triple nega -
Rexahn, Haichang collaborate for developing liver cancer treatment
biospectrumasia
February 11, 2018Any clinical trials conducted by Haichang will be designed to meet both U.S. and Chinese regulatory requirements.
Pharma Sources Insight January 2025
